Clinical Trial Update: Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial evaluating 908/RTV with other protease inhibitors in multi-PI-experienced HIV patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV-1 | Phase 3 | Status: TERMINATED